Eur Rev Med Pharmacol Sci 2020; 24 (14): 7673-7680

DOI: 10.26355/eurrev_202007_22268

Expression and clinical significance of miR-193a-3p in invasive pituitary adenomas

W.-J. Su, J.-S. Wang, M.-D. Ye, W.-L. Chen, C.-X. Liao

Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. chenwenli06@163.com


OBJECTIVE: Our study aimed to investigate miR-193a-3p expression and its clinical significance in pituitary adenomas (PAs). Moreover, the correlation between miR-193a-3p expression and the invasiveness of PAs was explored.

PATIENTS AND METHODS: In this study, the relative expression levels of miR-193a-3p were detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The correlations between miR-193a-3p and tumor size, clinical features, and prolactinomas postoperative prolactin (PRL) levels early remission were further analyzed.

RESULTS: Compared with non-invasive PAs, there was a lower miR-193a-3p expression in invasive PAs. MiR-193a-3p expression had reverse relevance to tumor size. A higher risk of postoperative residual and recurrence was found in patients with downregulated miR-193a-3p. Prolactinomas patients with postoperative PRL levels early remission were at lower risk to relapse and patients with high-expression miR-193a-3p had a higher early remission rate, suggesting that miR-193a-3p was a significant prognostic factor for prolactinomas.

CONCLUSIONS: MiR-193a-3p could have potential therapeutic value for invasive pituitary adenomas.

Free PDF Download

To cite this article

W.-J. Su, J.-S. Wang, M.-D. Ye, W.-L. Chen, C.-X. Liao
Expression and clinical significance of miR-193a-3p in invasive pituitary adenomas

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 14
Pages: 7673-7680
DOI: 10.26355/eurrev_202007_22268